Compassion Meditation for Veterans with Posttraumatic Stress Disorder (PTSD): a Nonrandomized Study.
Ariel J Lang, Pollyanna Casmar, Samantha Hurst, Timothy Harrison, Shahrokh Golshan, Raquel C Good, Michael Essex, Lobsang Negi
Mindfulness January 1, 2020 DOI: 10.1007/s12671-017-0866-z (opens in new tab) via PubMed
Summary
AI-generated from the abstractCompassion meditation, specifically a manualized protocol called Cognitively Based Compassion Training for Veterans (CBCT-Vet), appears acceptable to Veterans with PTSD. In an open trial with 36 Veterans across four groups, participation in 8-10 sessions of CBCT-Vet was associated with reductions in PTSD symptoms and depression, though causality cannot be inferred due to the nonrandomized design. No changes were observed in positive emotion or social connectedness. These preliminary results support further exploration of compassion meditation as part of recovery for Veterans with PTSD.
Study at a glance
| Characteristics | Open trial Randomized Qualitative Peer reviewed |
|---|---|
| Sample size | 36 |
| Population | Veterans with PTSD |
| Duration | 8-10 sessions, each lasting 90-120 minutes |
| Topics | Meditation PTSD |
| Keywords | Compassion |
| Key finding | Participation in CBCT-Vet was associated with reduced symptoms of PTSD and depression, but not with changes in positive emotion or social connectedness. |
Abstract
Compassion meditation (CM) is a contemplative practice that is intended to cultivate the ability to extend and sustain compassion toward self and others. Although research documents the benefits of CM in healthy populations, its use in the context of psychopathology is largely unexamined. The purpose of this study was to refine and initially evaluate a CM protocol, Cognitively Based Compassion Training (CBCT®), for use with Veterans with PTSD. To this end, our research team developed and refined a manualized protocol, CBCT-Vet, over 4 sets of groups involving 36 Veterans. This protocol was delivered in 8-10 sessions, each lasting 90-120 min and led by a CBCT®-trained clinical psychologist. Quantitative and qualitative data were used to identify areas to be improved and to assess change that occurred during the treatment period. Based on pooled data from this series of groups, CM appears to be acceptable to Veterans with PTSD. Group participation was associated with reduced symptoms of PTSD (partial eta squared = .27) and depression (partial eta squared = .19), but causality should not be inferred given the nonrandomized design. No change was observed in additional outcomes, including positive emotion and social connectedness. The results of this open trial support additional exploration of CM as part of the recovery process for Veterans with PTSD.